Nonalcoholic Fatty Liver Disease Predicts Acute Kidney Injury Readmission in Heart Failure Hospitalizations: A Nationwide Analysis

Nonalcoholic fatty liver disease (NAFLD) has been associated with the progression of chronic kidney disease. However, limited data is available on its impact on acute kidney injury (AKI) in heart fail-ure(HF) patients. All primary adult HF admissions from the national readmission database of 2016-2019 were identified. Admissions from July to December of each year were excluded to allow 6 months of follow-up. Patients were stratified according to the presence of NAFLD. Complex multivariate cox regression was used to adjust for confounders and calculate the adjusted hazard ratio. A total of 420,893 weighted patients admitted with HF were included in our cohort, of whom 780 had a secondary diagnosis of NAFLD. Patients with NAFLD were younger, more likely to be female, and had higher rates of obesity and diabetes mellitus. Both groups had similar rates of chronic kidney disease irrespective of the stage. NAFLD was associated with an increased risk of 6 -month readmission with AKI (26.8% vs 16.6%, adjusted hazard ratio:1.44, 95% CI [1.14-1.82], P = 0.003). The mean time to AKI readmission was 150 & PLUSMN; 44 days. NAFLD was associated with a shorter mean time to readmission (145 & PLUSMN; 45 vs 155 & PLUSMN; 42 days, b = -10 days, P = 0.044). Our study from a national data-base suggests that NAFLD is an independent predictor of 6-months readmission with AKI in patients admit-ted with HF. Further research is warranted to validate these findings. (Curr Probl Cardiol 2023;48:101816.)

Automated summary

Nonalcoholic fatty liver disease (NAFLD) is associated with the progression of chronic kidney disease. Limited data is available on its impact on acute kidney injury (AKI) in heart failure (HF) patients. This study found that NAFLD is associated with an increased risk of 6-month readmission with AKI in HF patients.